The first case-control study of 40 cases and 40 age- and race-matched controls among premenopausal and postmenopausal women failed to show any association of intact, fragmented, or total IGFBP-3 levels with the risk of breast cancer [22]. The gene discussed is IGFBP3; the disease is breast carcinoma.